Black Diamond Therapeutics Competitors and Similar CompaniesClear all
Black Diamond Therapeutics's competitors and similar companies include Replimune and RS Research.
 RS Research RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy. | |||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Toronto, CA New York, US Stony Brook, US | Locations Woburn, US HQ Milton, GB Woburn, US | Locations Epalinges, CH HQ |
Employees | Employees 6526% decrease | Employees 10422% increase | Employees 264% increase |
Valuation ($) | Valuation ($) 165 m | Valuation ($) 823.3 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($69.7m) (FY, 2024) | Net income ($215.8m) (FY, 2024) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 202.1m | Total funding raised $ 30m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Replimune
HQ
Woburn, US
Employees
104↑ 22% increase
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
View companyRS Research
HQ
Epalinges, CH
Employees
26↑ 4% increase
RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy.
View company